Overview

The Effect of Brimonidine

Status:
Completed
Trial end date:
2019-07-20
Target enrollment:
Participant gender:
Summary
This study will evaluate whether pre-treating patients with Brimonidine 0.2% before and/or after dilating the pupils will help to control the changes in intraocular pressure often seen when using dilating drops. The study will also evaluate the effects of different sequences of administering dilating drops along with Brimonidine on pupil size and reactivity.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Brimonidine Tartrate
Oxymetazoline
Phenylephrine
Tropicamide